Ventracor Limited

by Mary Thompson A number of interesting studies came out of this year’s American College of Cardiology (ACC) meeting, held in March in Orlando, FL, providing some good (and a few not so good) results

By filling in gaps in the continuum of care, new technologies are shifting the management of heart failure from the palliation of a terminal illness to the management of a chronic disease. by Mary Stu

When we first became acquainted with Houston’s MicroMed Cardiovascular Inc. (then known as MicroMed Technology) in 1998, the start-up sought to bring left ventricular assist devices (LVADs) into t

In medtech sectors where it can take decades to get a device to market, companies face the real and ever-present danger that by the time they launch their latest generation product, their technology h